Sector portfolio · VC firm · Australia

Brandon Capital's Biotech portfolio

Brandon Capital has backed 14 Biotech startups in rounds we track, $1.1B between them, shown by the stage each has reached. The best-funded is Advancell.

14startups backed
5stages
$1.1Braised between them
Series Bbiggest stage

Brandon Capital's whole portfolioBrandon Capital's profile

Segment by segment

Series B

4 startups · $200M raised

  1. Pheon TherapeuticsPheon Therapeutics is a biotechnology company focused on developing next-generation Antibody-Drug Conjugates (ADCs) aimed at treatUnited Kingdom$120M
  2. Pathios TherapeuticsPathios Therapeutics is a clinical-stage biotechnology company based in Oxford, UK, founded in 2017.United Kingdom$34M
  3. ENA RespiratoryEna Respiratory researches and develops solutions to transform the treatment and prevention of respiratory infections.Australia$24M
  4. AravaxAravax is a clinical-stage biotechnology company focused on developing innovative immunotherapies for food allergies.Australia$22M

Series C and later

4 startups · $620M raised

  1. AdvanCellAdvanCell is radiopharmaceutical firm that has developed the Targeted Alpha Therapy platform technology, a cutting-edge cancer treatment.Australia$438M
  2. VaxxasVaxxas Pty Ltd is a clinical-stage biotechnology company based in Brisbane, Queensland, Australia.Australia$89M
  3. Allay TherapeuticsAllay Therapeutics is a clinical-stage biotechnology company based in San Jose, California, with operations in Singapore.United States$58M
  4. PolyActivaPolyActiva is a Melbourne-based biotechnology company founded in 2010, specializing in innovative drug delivery technology for ophAustralia$35M

Pre-seed and seed

2 startups · $13M raised

  1. Amaroq TherapeuticsAmaroq Therapeutics is a biotechnology company based in New Zealand that focuses on developing innovative cancer therapeutics targNew Zealand$9.7M
  2. MirugenMirugen is a preclinical biotechnology company identifying the optimal set of cellular instructions to ask one cell type to become another.Australia$2.9M

Series A

2 startups · $239M raised

  1. AstronauTxAstronauTx Ltd.United Kingdom$124M
  2. Myricx BioMyricx Bio is a biotechnology company that develops novel NMT inhibitor payloads for ADCs to treat cancer.United Kingdom$115M

Stage not reported

2 startups · $23M raised

  1. OkogenOkogenis is a developer of ophthalmic anti-infective drugs.United States$13M
  2. TamoRxTamoRx is a Biotech company that is focused on research and development of biological mechanism within cells for cancer treatment.New Zealand$9.9M

How this map is made. Every startup here works in Biotech and has raised money in a round we track that names Brandon Capital as an investor. Each sits under the stage of its latest round. Rebuilt nightly; updated 15 November 2026.

More portfolio maps

All portfolios

Raising from investors like Brandon Capital?

Find the investors who back startups like yours, with their cheques, rounds and partners, in the app with filters, lists and exports.